Two Sigma Advisers’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,250
Closed -$44.3K 2613
2024
Q4
$44.3K Sell
12,250
-66,100
-84% -$239K ﹤0.01% 2290
2024
Q3
$138K Sell
78,350
-17,500
-18% -$30.8K ﹤0.01% 2132
2024
Q2
$150K Sell
95,850
-46,500
-33% -$72.5K ﹤0.01% 2270
2024
Q1
$278K Sell
142,350
-5,400
-4% -$10.5K ﹤0.01% 2097
2023
Q4
$208K Sell
147,750
-41,500
-22% -$58.5K ﹤0.01% 2218
2023
Q3
$299K Sell
189,250
-189,600
-50% -$300K ﹤0.01% 1979
2023
Q2
$818K Buy
378,850
+225,400
+147% +$487K ﹤0.01% 1610
2023
Q1
$322K Sell
153,450
-2,700
-2% -$5.67K ﹤0.01% 2110
2022
Q4
$342K Sell
156,150
-27,000
-15% -$59.1K ﹤0.01% 2022
2022
Q3
$549K Sell
183,150
-800
-0.4% -$2.4K ﹤0.01% 1806
2022
Q2
$521K Sell
183,950
-13,600
-7% -$38.5K ﹤0.01% 1905
2022
Q1
$1.06M Sell
197,550
-189,802
-49% -$1.02M ﹤0.01% 1608
2021
Q4
$2.89M Sell
387,352
-95,098
-20% -$711K 0.01% 1010
2021
Q3
$4.38M Buy
482,450
+362,500
+302% +$3.29M 0.01% 856
2021
Q2
$585K Buy
119,950
+105,850
+751% +$516K ﹤0.01% 1873
2021
Q1
$63K Sell
14,100
-70,850
-83% -$317K ﹤0.01% 2486
2020
Q4
$330K Sell
84,950
-83,300
-50% -$324K ﹤0.01% 2016
2020
Q3
$543K Buy
168,250
+87,300
+108% +$282K ﹤0.01% 1788
2020
Q2
$359K Buy
80,950
+44,600
+123% +$198K ﹤0.01% 2043
2020
Q1
$102K Buy
+36,350
New +$102K ﹤0.01% 2298
2019
Q3
Sell
-850
Closed -$4K 2419
2019
Q2
$4K Hold
850
﹤0.01% 2292
2019
Q1
$7K Hold
850
﹤0.01% 2271
2018
Q4
$6K Buy
850
+14
+2% +$99 ﹤0.01% 2330
2018
Q3
$10K Buy
+836
New +$10K ﹤0.01% 2204